Michelle Fox is Chief Executive Officer of Semler Scientific and CardioVanta. She brings more than 20 years of experience in the med tech sector, with deep expertise in clinical governance, regulatory alignment, reimbursement strategy and the integration of medical affairs within complaint commercial frameworks. She has a track record of scaling clinical and commercial infrastructure to drive sustainable growth and practice change.   

Prior to her appointment as CEO, Michelle held senior leadership roles at Teleflex following the company’s acquisition of Vidacare in December 2013. She most recently served as the Corporate Vice President and Chief Medical Officer, where she scaled a global Clinical and Medical Affairs organization. In that capacity, she oversaw clinical development, medical strategy, scientific engagement, government affairs, health policy, and reimbursement, ensuring alignment with regulatory standards and corporate compliance requirements.

Throughout her career, Michelle has built and led clinical infrastructure designed to support the safe and appropriate use of products to advance patient care. She led evidence generation, adherence to evolving regulatory and reimbursement frameworks globally. She has extensive experience operating in highly regulated environments and working cross-functionally to embed compliance and transparent decision making into clinical and commercial processes.

Michelles’ leadership has focused on organizational development at the intersection of medicine, innovation, and systems change. She is recognized for translating clinical evidence into practice through professional society engagement, regulatory alignment, and interactive medical education. Her approach combines deep clinical expertise with the ability to lead cross-functional and geographically diverse teams in complex regulatory and commercial environments.  She has lectured nationally and internationally on the operational impact of strong Clinical and Medical Affairs functions and their ability to align with professional societies and regulatory standards and deliver on governance requirements.

Michelle serves the Chair of the Board of Directors of the Massachusetts Medical Device Industry Council (MassMEDIC), where she served as a board member beginning in 2020. Her appointment as Chair reflects her longstanding commitment to advancing the MedTech ecosystem and advancing patient care by shaping policy innovation and industry growth.

Michelle holds a Bachelor of Science in Nursing from Colby-Sawyer College, which at the time operated in academic affiliation with Dartmouth. She completed a Critical Care Residency at Beth Israel Deaconess Medical Center. She has held advisory positions with both medical and nursing societies and has contributed to the development of professional standards in multiple specialty areas. Her work consistently reflects a clinical-first orientation, with an emphasis on patient outcomes, operational scalability, and compliance with medical policy frameworks. 

 

Michelle is based in Boston, MA, USA.